Back
Bio-Rad Laboratories, Inc. (BIO)
Life Sciences Tools & ServicesBIO · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$390.39
+2.45%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$27.85
ROE
2.5%
Gross margin
52.0%
Debt/Equity
0.20x
Revenue growth
1.1%
Bio-Rad Laboratories, Inc. — company intelligence
Earnings surprises
Q2 2026$2.62 vs $1.77 est+48.4%
Q1 2026$1.89 vs $2.00 est-5.7%
Q4 2025$2.51 vs $2.73 est-8.0%
Q3 2025$2.26 vs $1.95 est+15.7%
Analyst consensus · 10 analysts
5 Buy4 Hold1 Sell
Updated Aug 16, 2026
Recent SEC filings
10-Q — Quarterly reportAug 4, 2026
8-K — Material event reportAug 4, 2026
4 — Insider transaction reportJul 28, 2026
Latest news
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.